Weifang Sheng Tai Pharmaceutical Co., Ltd.

On Chemball

My Chemball

As Supplier

My RFQ Manage Products

As Buyer

My RFQ Post RFQ

My Account

+86-571-8627 3270

Weifang Sheng Tai Pharmaceutical Co., Ltd.

25 YRS

Shandong, China

CNY 95.3 Million

333000 m²

500-1000 people

Main Products: D-Glucose Monohydrate / Aldehydo-D-Glucose / Starch / Dextrin

Shandong, China

Contact Supplier

Home Company Profile Contact Us Post Buying Request

ABOUT US

Weifang Sheng Tai Pharmaceutical Co., Ltd. established in February 1999, is located in the east of Changda Road, development zone, Changle County. It is mainly engaged in the R&D, manufacturing and sales of starch and glucose, with an annual output of 400000 tons of starch products and 300000 tons of glucose products. The leading products sell well in 30 provinces (cities and autonomous regions) and are exported to nearly 70 countries and regions. In 2017, the company achieved a sales revenue of 1.72 billion yuan and paid in taxes of 35.76 million yuan. Since this year, it has continued to maintain a good momentum of healthy and rapid development. The company has total assets of 1.8 billion yuan and 760 employees, of which professional and technical personnel account for more than 20%. It has 2 starch workshops and 2 glucose workshops, complete facilities and equipment, and advanced production and technology. It has successively passed GMP, ISO9001, GB / t22000, ISO14001, OHSAS18001 and QS, IP, halal, kosher and other series system certification. It has nearly 30 patents. It has been awarded the honorary titles of "high-tech enterprise", "key leading enterprise of agricultural industrialization" in Shandong Province, Weifang "top 100 industrial enterprises" and "top 50 agricultural leading enterprises". In recent years, focusing on supply adjustment and high-end transformation, the company has made great efforts to rely on technological progress and refined management, continuously optimize the structure, improve products and services, continuously broaden market channels at home and abroad, especially the growing high-end customer group. We will continue to promote automation and intelligent transformation of existing production lines, spare no effort to promote capacity release, quality improvement, efficiency improvement and environmental improvement, and continuously consolidate and expand the core competitive advantage of the enterprise. Facing the future, the company will continue to follow the idea of "making high-quality products, taking the high-end and creating the first-class" and connotative development, adhere to the concept of "winning by specialty, winning by difference and winning by innovation", explore operation, strict management, efficient investment and innovative development, promote the long-term healthy and effective growth of the enterprise, and strive to become the "top 500 in China" and "top 500 in the world" as soon as possible.

Basic Information